ArticleCancer biomarkers : section A of Disease markers2019

Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.

Huiping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.